Three-Year-Old Boy's Metastatic Cancer Disappears After Two Shots of Experimental Cell Therapy
Three-Year-Old Boy's Metastatic Cancer Disappears After Two Shots of Experimental Cell Therapy SingularityHub
Three-Year-Old Boy's Metastatic Cancer Disappears After Two Shots of Experimental Cell Therapy SingularityHub
Aastha Naik: Advancing Equitable Cancer Research Capacity Across LMICs Oncodaily
A single inherited EGFR mutation may increase lung cancer risk more than 60 times among individuals who never smoked. An evaluation of more than 3 million people showed the EGFR T790M variant increased risk for lung cancer 25 times overall, with a substantially larger impact on patients who reported never smoking…
Томские ученые создали прототип мРНК-вакцины против рака легкого UfacityNews.ru
How Paxalisib Targets Treatment Resistance in Breast Cancer Cure Today
Nurse-Led Support Reduces Death Anxiety in Breast Cancer Care Oncology Nursing News
$10M invested to research soundwave cancer treatments at the University of Michigan MLive.com
Paycom’s Jeff York Gives Back to the Cancer Center That Saved Him D Magazine
Antengene Begins Phase III Gastric Cancer Trial in China for CLDN18.2 ADC GenomeWeb
New research from the Garvan Institute of Medical Research has revealed for the first time that two closely related bowel diseases, currently treated in the same way, are fundamentally different. The findings help explain why one carries a much higher risk of colon cancer—and point to the need for different approaches…
Why Does Cancer Research Need a Global Approach? – NCI Center for Global Health Oncodaily
How Can AI Help Cancer Practices Improve Care and Clinical Research? BioPharm International
Until now, diagnosing skin tumors has relied on detecting visible changes to the skin, and Line-Field Confocal Optical Coherence Tomography (LC-OCT) is a well-established method used for diagnosis. Now, researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) led by Dr. Moritz Ronicke from the Department…
New hope for patients with pancreatic cancer: Intermountain Health oncologists say new drug just approved by FDA may be a “Game Changer” for cancer patients ABC4 Utah